Does KSM-66 Ashwagandha Actually Raise Testosterone? What the Evidence Shows in 2026

KSM-66 ashwagandha produces real but modest increases in testosterone—roughly 15–25% above baseline in clinical trials—and the gains are most consistent in men under chronic stress or engaged in resistance training. That's meaningfully different from the effect of prescription testosterone therapy, and understanding that gap matters before you spend money on either.

What the Clinical Trials Actually Found

The most-cited trial randomized healthy young men to 300 mg KSM-66 twice daily or placebo for eight weeks alongside a standardized resistance program. The ashwagandha group gained an average of 96 ng/dL in total testosterone versus 18 ng/dL in placebo (p = 0.004) [1][12]. Muscle strength and body-fat reductions were also significantly better in the supplement group. A separate randomized controlled trial in men with mild sexual dysfunction found statistically significant testosterone increases and improved sexual-function scores, with prolactin unchanged—suggesting the mechanism runs through the HPG axis rather than prolactin suppression [2][4].

A 90-day study in infertile men found testosterone rose 17% and LH rose 34%, with sperm concentration jumping roughly 167% [10]. The LH increase is the critical detail: it implies ashwagandha is stimulating upstream hypothalamic-pituitary signaling rather than acting as a direct androgen precursor. That's the same general mechanism as Clomid (clomiphene) and enclomiphene (Androxal)—both SERMs used in clinical practice to raise endogenous LH and testosterone without suppressing fertility. Ashwagandha's effect is weaker and less predictable than either SERM, but it shares the fertility-preserving logic.

For comparison, consider what Sattler et al. (2009, JAMA) demonstrated with dose-escalating testosterone gel in older men: even low pharmacologic doses produced muscle-strength gains that dwarf what any supplement trial has reported. The Testosterone Trials (TTrials), the NIH-funded seven-arm study, confirmed that replacing testosterone to mid-normal range in genuinely hypogonadal older men improved bone density, sexual function, and vitality. KSM-66 is operating in a different weight class—but it's not a placebo.

For men who want to understand where hormone optimization fits before considering prescriptions, the hormone optimization treatment hub covers the clinical pathway from labs through therapy options.

Where It Works and Where It Doesn't

The honest read of the data is that KSM-66 delivers results primarily in two populations: stressed men with cortisol-suppressed testosterone (functional, not structural hypogonadism) and healthy men in resistance training who are already in normal testosterone ranges. The proposed mechanism—cortisol reduction freeing up HPG-axis output—is physiologically coherent and supported by the Shoden extract trial showing 14.7% higher salivary testosterone and an 18% rise in DHEA-S versus placebo in overweight men with fatigue [1].

What KSM-66 will not do: rescue a man whose testosterone is low because of primary testicular failure, significant obesity-driven aromatization, or pituitary pathology. The Endocrine Society Clinical Practice Guidelines on male hypogonadism are explicit that supplement-level interventions are not substitutes for diagnosed hypogonadism treatment. If your total testosterone is consistently below 300 ng/dL with symptoms, you need a clinical workup—not an adaptogen. Providers like Marek Health run the labs and distinguish functional from structural hypogonadism before recommending any therapy.

Safety data for KSM-66 at 300–600 mg daily over 8–12 weeks are generally clean across trials—no significant changes in liver enzymes, hematology, or thyroid panels in the resistance-training studies. However, isolated case reports of thyrotoxicosis linked to ashwagandha use are real [16], and anyone with existing thyroid disease should flag use to their physician. Long-term endocrine effects beyond three months remain understudied.

It's also worth reading how other natural T-boosters compare structurally—our breakdown of why fenugreek raises testosterone and libido and the Nugenix vs. prescription TRT comparison put supplement-tier evidence in useful context against the clinical standard.

---

Frequently asked questions

Does ashwagandha raise testosterone as much as TRT?

No—KSM-66 raises testosterone by roughly 15–25% in clinical trials, while prescription testosterone therapy (gels like AndroGel or injectables like Depo-Testosterone) can double or triple levels in hypogonadal men. The Testosterone Trials (TTrials) confirmed that pharmacologic replacement produces functional improvements—in bone density, sexual function, and vitality—that no supplement trial has replicated at comparable effect sizes. KSM-66 is appropriate for men in the low-normal range with stress-related suppression; it is not a clinical substitute for documented hypogonadism treatment.

What dose of KSM-66 is supported by evidence?

The most replicated effective dose is 300 mg twice daily (600 mg/day total), which is the protocol used in the key resistance-training RCT and the sexual-function trial [2][12]. Some trials use 600 mg once daily with similar outcomes. There is no strong evidence that doses above 600 mg/day produce additional testosterone benefit, and higher doses introduce greater uncertainty around thyroid and hepatic safety.

Can men on TRT take ashwagandha safely?

There is no controlled trial data on ashwagandha combined with prescription testosterone formulations. The theoretical concern is additive endocrine stimulation, particularly on thyroid or adrenal axes, and potential interactions with how the body clears androgens.